| Produktname | Mosapride Citrate |
|---|---|
| CAS-Nummer | 112885-42-4 |
| Molekülformel | C21H25ClFN3O3 · C6H8O7 |
| Molekulargewicht | 614.0 |
| Aussehen | Weißes bis cremefarbenes kristallines Pulver |
| Analyse (HPLC) | ≥98.5% |
| Trocknungsverlust | ≤0,5% |
| Verbrennungsrückstand | ≤0,1% |
| Schwermetalle | ≤ 10 ppm |
| Schmelzpunkt | 145-150°C |
| Spezifische Rotation | Nicht zutreffend (racemisches Gemisch) |
Brauchst du Hilfe? Kontaktieren Sie unser Team

Mosapride citrate, 4-Amino-5-chloro-2-ethoxy-N-[[4-(4-fluorobenzyl)-2-morpholinyl]methyl]benzamide citrate, Mosapride, AD-5423, Mosapride citrate salt
Mosapride citrate is a well-regarded gastroprokinetic agent that works by selectively stimulating 5-HT4 receptors in the gut. It enhances gastrointestinal motility without the extrapyramidal side effects often seen with older dopamine antagonists. For formulators, that means a reliable option for managing functional dyspepsia, GERD, and other motility disorders.
We supply mosapride citrate as a high-purity crystalline powder, ideal for oral solid dosage forms. Every batch is tested to meet strict specifications, and we provide complete documentation with each shipment. Our supply chain is flexible, supporting everything from small R&D quantities to full-scale commercial production.